The Stanford spinout is working on technology that enables the real-time mapping of the brain and has now secured a total of $11.5m in funding.
Inscopix, a Stanford University spinout developing brain mapping technology, has raised $10m in series A funding led by Playground Ventures, with participation from AME Cloud Ventures and the Floodgate Fund.
Founded in 2011, Inscopix is developing real-time brain imaging technology, dubbed NVista. The approach makes it possible to design more efficient therapies for neurological and psychiatric disorders.
NVista is based on research conducted in the lab of Mark Schnitzer by Eric Cocker and Kunal Ghosh.
The capital injection will support research and development towards further development of Inscopix’s platform and the commercial scale-up of the technology.
Inscopix has secured $11.5m to date. The Floodgate Fund and F-Prime Capital, the investment arm of financial services conglomerate Fidelity International then known as Fidelity Biosciences, co-led a seed round in 2011 at the time of the company’s launch.
Mark Valdez, principal at Playground, said: “Inscopix has built an incredible product ecosystem to-date, but we believe an even bigger opportunity exists to further develop core hardware and software infrastructure that drives forward the future for brain research.
“We are excited to lead this round of financing and to partner with the Inscopix team as they set out to achieve their ultimate vision.”
